A carregar...
Advances in the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Hodgkin's lymphoma (HL) is diagnosed in 20,000 men and women annually in North America and Europe. Despite treatment advancements for HL resulting in an overall survival rate of 80%, patients with advanced stage disease continue to have suboptimal outcomes, with relapse rates of 30%–40%. An add...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3316922/ https://ncbi.nlm.nih.gov/pubmed/22387318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|